Indication
Renal Cell Carcinoma
The Renal Cell Carcinoma pipeline: 2 tracked drugs, 1 approved for this indication.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Renal Cell Carcinoma, so this list is not complete.
1 approved / phase 41 Phase 1/2
Compare the share prices of listed companies in Renal Cell Carcinoma →
Market size not yet sourced. How markets are sized ↗